BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9602330)

  • 1. No evidence for c-erbB-2 overexpression in gastric carcinogenesis.
    Blok P; Craanen ME; Dekker W; Offerhaus GJ; Tytgat GN
    Histopathology; 1998 Apr; 32(4):335-9. PubMed ID: 9602330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronology of p53 protein accumulation in gastric carcinogenesis.
    Craanen ME; Blok P; Dekker W; Offerhaus GJ; Tytgat GN
    Gut; 1995 Jun; 36(6):848-52. PubMed ID: 7615272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No evidence for functional inactivation of wild-type p53 protein by MDM2 overexpression in gastric carcinogenesis.
    Blok P; Craanen ME; Dekker W; Offerhaus GJ; Tytgat GN
    J Pathol; 1998 Sep; 186(1):36-40. PubMed ID: 9875138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of cyclin D1 overexpression in gastric carcinogenesis.
    Blok P; Craanen ME; van Diest PJ; Dekker W; Tytgat GN
    Histopathology; 2000 Feb; 36(2):151-5. PubMed ID: 10672060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of epidermal growth factor receptor family proteins (EGFR, c-erbB-2 and c-erbB-3) in gastric cancer and chronic gastritis.
    Slesak B; Harlozinska A; Porebska I; Bojarowski T; Lapinska J; Rzeszutko M; Wojnar A
    Anticancer Res; 1998; 18(4A):2727-32. PubMed ID: 9703936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p21(Waf1/Cip1) expression and the p53/MDM2 feedback loop in gastric carcinogenesis.
    Craanen ME; Blok P; Offerhaus GJ; Meijer GA; Dekker W; Kuipers EJ; Meuwissen SG
    J Pathol; 1999 Dec; 189(4):481-6. PubMed ID: 10629547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of p53 expression in precancerous and malignant gastric mucosa.
    Romiti A; Moretti A; Vecchione A; Muraro R; Feudi ML; Rinaldi V; Mancini R; Valli C; Mozzicafreddo A; Frati L; Tomao S
    Oncol Rep; 1998; 5(1):109-13. PubMed ID: 9458303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of toll-like receptors (TLR) 2, 4 and 5 in gastric dysplasia.
    Pimentel-Nunes P; Afonso L; Lopes P; Roncon-Albuquerque R; Gonçalves N; Henrique R; Moreira-Dias L; Leite-Moreira AF; Dinis-Ribeiro M
    Pathol Oncol Res; 2011 Sep; 17(3):677-83. PubMed ID: 21455638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of E-cadherin expression in early gastric cancer.
    Blok P; Craanen ME; Dekker W; Tytgat GN
    Histopathology; 1999 May; 34(5):410-5. PubMed ID: 10231415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The prognostic significance of expression of c-met oncogene and its relation to gastric mucosal lesions].
    Zhuang X; Zheng J; Lin S; Sun G; Li Y
    Zhonghua Bing Li Xue Za Zhi; 2000 Dec; 29(6):409-11. PubMed ID: 11866940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of p53, c-erbB-2 and Ki67 in intestinal metaplasia and gastric carcinoma.
    Zheng Y; Wang L; Zhang JP; Yang JY; Zhao ZM; Zhang XY
    World J Gastroenterol; 2010 Jan; 16(3):339-44. PubMed ID: 20082479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of syndecan-1 at different stages in the course of gastric carcinoma and its significance].
    Xi YX; Song X; Chen J; Chen HX; Peng TS; Lin HL; Chen MH
    Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):193-6. PubMed ID: 17649635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathological disorders of the gastric mucosa surrounding carcinomas and primary lymphomas.
    Arista-Nasr J; Jiménez-Rosas F; Uribe-Uribe N; Herrera-Goepfert R; Lazos-Ochoa M
    Am J Gastroenterol; 2001 Jun; 96(6):1746-50. PubMed ID: 11419824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CORRELATION BETWEEN C-erbB-2 WITH GASTRIC MUCOSAL ATYPICAL HYPERPLASIA AND GASTRIC CARCINOMA.
    Song B; Yu J; Wu TS
    J Biol Regul Homeost Agents; 2015; 29(2):471-7. PubMed ID: 26122239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of claudin-2 in the multistage process of gastric carcinogenesis.
    Song X; Li X; Tang Y; Chen H; Wong B; Wang J; Chen M
    Histol Histopathol; 2008 Jun; 23(6):673-82. PubMed ID: 18366005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression and significance of caudal type transcription factor-2 in gastric mucosa at different stages of gastric carcinogenesis].
    Chen HX; Chen MH; Song X
    Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(4):247-9. PubMed ID: 16677504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bax and Bcl-2 protein expression in gastric precancerous lesions: immunohistochemical study.
    Anagnostopoulos GK; Stefanou D; Arkoumani E; Sakorafas G; Pavlakis G; Arvanitidis D; Tsianos E; Agnantis NJ
    J Gastroenterol Hepatol; 2005 Nov; 20(11):1674-8. PubMed ID: 16246184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Helicobacter pylori in gastric carcinoma.
    Prabhu SR; Amrapurkar AD; Amrapurkar DN
    Natl Med J India; 1995; 8(2):58-60. PubMed ID: 7735060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence that gastric pit dysplasia-like atypia is a neoplastic precursor lesion.
    Agoston AT; Odze RD
    Hum Pathol; 2014 Mar; 45(3):446-55. PubMed ID: 24529328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of CDX2 and villin in gastric cardiac intestinal metaplasia and the relation with gastric cardiac carcinogenesis.
    Xiao ZY; Ru Y; Sun JT; Gao SG; Wang YF; Wang LD; Feng XS
    Asian Pac J Cancer Prev; 2012; 13(1):247-50. PubMed ID: 22502678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.